Dr. George Somlo on Advances in Multiple Myeloma

Dr. George Somlo, MD
Published: Monday, Oct 03, 2016


Dr. George Somlo, MD, medical oncologist, City of Hope, discusses recent highlights in multiple myeloma.
 
Several new agents have been approved by the FDA in the past year, and oncologists are quickly learning how to best use them, says Somlo.
 
More and more patients are experiencing complete remissions, or at the least, very good partial remissions that eliminate 90% of the mutational load. Many of those patients can then receive an autologous stem cell transplant and the receive maintenance therapy, accomplishing minimal residual disease.
 
This directly translates into longer survival and a dramatically improved quality of life, says Somlo.
 
Oncologists that treat patients with multiple myeloma need to be aggressive, use the latest tools and agents, and enroll patients in clinical trials when applicable, says Somlo.
 

Dr. George Somlo, MD, medical oncologist, City of Hope, discusses recent highlights in multiple myeloma.
 
Several new agents have been approved by the FDA in the past year, and oncologists are quickly learning how to best use them, says Somlo.
 
More and more patients are experiencing complete remissions, or at the least, very good partial remissions that eliminate 90% of the mutational load. Many of those patients can then receive an autologous stem cell transplant and the receive maintenance therapy, accomplishing minimal residual disease.
 
This directly translates into longer survival and a dramatically improved quality of life, says Somlo.
 
Oncologists that treat patients with multiple myeloma need to be aggressive, use the latest tools and agents, and enroll patients in clinical trials when applicable, says Somlo.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x